Feed Preview

Going Viral

Alzheimer's Disease: RNA Regulation

Alzheimer's Disease: RNA Regulation diagram by Shelton et al, PLOS Genetics
Shelton et al, PLOS Genetics

RNA regulation involves several mechanisms that are used by cells to decreases or increase the production of RNA. Issues with RNA regulation are associated with Alzheimer's Disease (AD). Here are the latest discoveries pertaining to RNA regulation and this disease.

Top 20 most recent papers
May 24, 2020

Spatial Pattern Separation in Early Alzheimer's Disease

Journal of Alzheimer's Disease : JAD
Martina ParizkovaJan Laczó
May 18, 2020

Effect of Peripheral Insulin Administration on Phosphorylation of Tau in the Brain

Journal of Alzheimer's Disease : JAD
Yanli JiangFei Liu
May 14, 2020

Abelson Kinases Mediate the Depression of Spontaneous Synaptic Activity Induced by Amyloid Beta 1-42 Peptides

Cellular and Molecular Neurobiology
M ReichensteinI Michaelevski
May 15, 2020
ReviewOpen Access

Relevance of biomarkers across different neurodegenerative

Alzheimer's Research & Therapy
Alexander J EhrenbergRoss W Paterson
May 18, 2020

Age Moderates Associations of Hypertension, White Matter Hyperintensities, and Cognition

Journal of Alzheimer's Disease : JAD
Anne Cristine GuevarraNagaendran Kandiah
May 24, 2020

Tau PET Imaging with [18F]PM-PBB3 in Frontotemporal Dementia with MAPT Mutation

Journal of Alzheimer's Disease : JAD
Ya SuXin Cheng
May 16, 2020

Increased nuclear but not cytoplasmic activities of CELF1 protein leads to muscle wasting

Human Molecular Genetics
Diana C CoxThomas A Cooper
May 24, 2020
Review

Hemodynamic Instability in Heart Failure Intensifies Age-Dependent Cognitive Decline

Journal of Alzheimer's Disease : JAD
Jack C de la Torre
May 18, 2020

Modeling Awareness in Alzheimer's Disease

Journal of Alzheimer's Disease : JAD
Jean-Pierre JacusPascal Antoine
May 18, 2020
Open Access

Gene Ontology Curation of Neuroinflammation Biology Improves the Interpretation of Alzheimer's Disease Gene Expression Data

Journal of Alzheimer's Disease : JAD
Barbara KramarzRuth C Lovering
May 18, 2020

Early-Stage Alzheimer's Disease Does Not Alter Pupil Responses to Colored Light Stimuli

Journal of Alzheimer's Disease : JAD
Aki KawasakiJulius Popp
May 18, 2020

Intrathecal immunoreactivity in people with or without previous infectious mononucleosis

Acta Neurologica Scandinavica
Daniel JonsOluf Andersen

See more papers from this feed

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/alzheimers-disease-rna-regulation/cf295a8b-d130-4ba5-9e4e-222d91a713df